Rapid PE Triage and Notification (PETN)

K220499

iSchemaView Inc. · cleared 2022-05-17 · product code QAS · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.3)
Rapid PE Triage and Notification (PETN) is a radiological computer aided triage and notification software indicated for use in the analysis of CTPA images.
Algorithmartificial intelligence algorithm
source quote (p.3)
Rapid PETN uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings on a server or standalone desktop application in parallel to the ongoing standard of care image interpretation. The PETN module is an AI/ML module.
Adaptive (vs locked)FDA source did not state this
PCCPFDA source did not state this
Cybersecurity addressedFDA source did not state this

Validation studies (2)

Retrospective clinical

n=600 cases

Standalone

n=306 cases

endpoints: Sensitivity; Specificity; processing time

standards: EN ISO 14971:2019, IEC 62304:2016, IEC 62366:2015, NEMA PS 3.1 - 3.20

Reported performance (2 observations)

sensitivity0.96CI 0.92,0.98
source quote (p.8)
The primary endpoint passed with Sensitivity = 0.96 (0.92,0.98) and Specificity = 0.89 (0.83,0.93).
specificity0.89CI 0.83,0.93
source quote (p.8)
The primary endpoint passed with Sensitivity = 0.96 (0.92,0.98) and Specificity = 0.89 (0.83,0.93).

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
0
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
1
drift signals on this device
  • re_clearance

    The FDA AI/ML device list shows a newer 510(k) K233512 (decision 2024-01-16) from iSchemaView, Inc. for a matching device line ("Rapid (6.0)") — a new clearance for the same line is a change event.

    first seen 2026-07-08 · k_number:K233512

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K220499